HEADER GTP-BINDING 21-JAN-97 1MH1 TITLE SMALL G-PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1 - 184; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 OTHER_DETAILS: COMPLEXED WITH GUANOSINE-5'-(BETA,GAMMA-IMIDO) COMPND 8 TRIPHOSPHATE (GPPNP) SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RHO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_GENE: RHO KEYWDS GTP-BINDING, GTPASE, SMALL G-PROTEIN, RHO FAMILY, RAS SUPER FAMILY EXPDTA X-RAY DIFFRACTION AUTHOR M.HIRSHBERG,R.W.STOCKLEY,G.DODSON,M.R.WEBB REVDAT 5 22-MAY-24 1MH1 1 REMARK REVDAT 4 09-AUG-23 1MH1 1 REMARK REVDAT 3 03-NOV-21 1MH1 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1MH1 1 VERSN REVDAT 1 21-JAN-98 1MH1 0 JRNL AUTH M.HIRSHBERG,R.W.STOCKLEY,G.DODSON,M.R.WEBB JRNL TITL THE CRYSTAL STRUCTURE OF HUMAN RAC1, A MEMBER OF THE JRNL TITL 2 RHO-FAMILY COMPLEXED WITH A GTP ANALOGUE. JRNL REF NAT.STRUCT.BIOL. V. 4 147 1997 JRNL REFN ISSN 1072-8368 JRNL PMID 9033596 JRNL DOI 10.1038/NSB0297-147 REMARK 2 REMARK 2 RESOLUTION. 1.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1378 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 256 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1MH1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000174997. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : DEC-94 REMARK 200 TEMPERATURE (KELVIN) : 101 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42134 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.380 REMARK 200 RESOLUTION RANGE LOW (A) : 51.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.03900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.38 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.13000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 821P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 23.22000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.52500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.22000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.52500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 182 REMARK 465 LYS A 183 REMARK 465 LYS A 184 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 32 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE A 33 CG1 CG2 CD1 REMARK 470 VAL A 36 CG1 CG2 REMARK 470 LYS A 123 CG CD CE NZ REMARK 470 GLU A 127 CG CD OE1 OE2 REMARK 470 LYS A 128 CG CD CE NZ REMARK 470 LYS A 130 CE NZ REMARK 470 GLU A 131 CD OE1 OE2 REMARK 470 LYS A 132 CD CE NZ REMARK 470 LYS A 133 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PHE A 28 CG PHE A 28 CD2 1.039 REMARK 500 PHE A 28 CG PHE A 28 CD1 1.046 REMARK 500 PHE A 28 CE1 PHE A 28 CZ 1.054 REMARK 500 PHE A 28 CZ PHE A 28 CE2 1.054 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 28 CB - CG - CD2 ANGL. DEV. = 28.6 DEGREES REMARK 500 PHE A 28 CD1 - CG - CD2 ANGL. DEV. = -58.3 DEGREES REMARK 500 PHE A 28 CB - CG - CD1 ANGL. DEV. = 29.8 DEGREES REMARK 500 PHE A 28 CG - CD1 - CE1 ANGL. DEV. = -90.7 DEGREES REMARK 500 PHE A 28 CG - CD2 - CE2 ANGL. DEV. = -90.9 DEGREES REMARK 500 PHE A 28 CD1 - CE1 - CZ ANGL. DEV. = -90.1 DEGREES REMARK 500 PHE A 28 CE1 - CZ - CE2 ANGL. DEV. = -60.0 DEGREES REMARK 500 PHE A 28 CZ - CE2 - CD2 ANGL. DEV. = -90.1 DEGREES REMARK 500 TYR A 40 CB - CG - CD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 TYR A 40 CB - CG - CD1 ANGL. DEV. = 4.3 DEGREES REMARK 500 ARG A 66 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 68 NE - CZ - NH1 ANGL. DEV. = 6.2 DEGREES REMARK 500 ARG A 68 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 ARG A 94 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG A 120 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 TYR A 139 CB - CG - CD2 ANGL. DEV. = 4.7 DEGREES REMARK 500 TYR A 139 CB - CG - CD1 ANGL. DEV. = -4.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 32 148.99 -7.32 REMARK 500 ILE A 33 116.38 172.02 REMARK 500 PHE A 37 81.85 74.78 REMARK 500 LYS A 96 -58.93 -129.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 201 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 17 OG1 REMARK 620 2 THR A 35 OG1 75.0 REMARK 620 3 GNP A 200 O2G 173.5 102.9 REMARK 620 4 GNP A 200 O2B 88.8 163.3 93.6 REMARK 620 5 HOH A 534 O 83.3 92.1 90.7 89.8 REMARK 620 6 HOH A 535 O 89.9 87.1 96.1 89.1 173.1 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GNP A 200 DBREF 1MH1 A 2 184 UNP P63000 RAC1_HUMAN 2 184 SEQADV 1MH1 SER A 78 UNP P63000 PHE 78 ENGINEERED MUTATION SEQRES 1 A 186 GLY SER PRO GLN ALA ILE LYS CYS VAL VAL VAL GLY ASP SEQRES 2 A 186 GLY ALA VAL GLY LYS THR CYS LEU LEU ILE SER TYR THR SEQRES 3 A 186 THR ASN ALA PHE PRO GLY GLU TYR ILE PRO THR VAL PHE SEQRES 4 A 186 ASP ASN TYR SER ALA ASN VAL MET VAL ASP GLY LYS PRO SEQRES 5 A 186 VAL ASN LEU GLY LEU TRP ASP THR ALA GLY GLN GLU ASP SEQRES 6 A 186 TYR ASP ARG LEU ARG PRO LEU SER TYR PRO GLN THR ASP SEQRES 7 A 186 VAL SER LEU ILE CYS PHE SER LEU VAL SER PRO ALA SER SEQRES 8 A 186 PHE GLU ASN VAL ARG ALA LYS TRP TYR PRO GLU VAL ARG SEQRES 9 A 186 HIS HIS CYS PRO ASN THR PRO ILE ILE LEU VAL GLY THR SEQRES 10 A 186 LYS LEU ASP LEU ARG ASP ASP LYS ASP THR ILE GLU LYS SEQRES 11 A 186 LEU LYS GLU LYS LYS LEU THR PRO ILE THR TYR PRO GLN SEQRES 12 A 186 GLY LEU ALA MET ALA LYS GLU ILE GLY ALA VAL LYS TYR SEQRES 13 A 186 LEU GLU CYS SER ALA LEU THR GLN ARG GLY LEU LYS THR SEQRES 14 A 186 VAL PHE ASP GLU ALA ILE ARG ALA VAL LEU CYS PRO PRO SEQRES 15 A 186 PRO VAL LYS LYS HET MG A 201 1 HET GNP A 200 32 HETNAM MG MAGNESIUM ION HETNAM GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER FORMUL 2 MG MG 2+ FORMUL 3 GNP C10 H17 N6 O13 P3 FORMUL 4 HOH *256(H2 O) HELIX 1 1 LYS A 16 THR A 25 1 10 HELIX 2 2 GLU A 62 SER A 71 5 10 HELIX 3 3 PRO A 87 ALA A 95 1 9 HELIX 4 4 TRP A 97 HIS A 104 1 8 HELIX 5 5 LEU A 117 ARG A 120 1 4 HELIX 6 6 LYS A 123 LYS A 130 1 8 HELIX 7 7 TYR A 139 GLU A 148 1 10 HELIX 8 8 LEU A 165 VAL A 176 1 12 SHEET 1 A 6 LYS A 153 GLU A 156 0 SHEET 2 A 6 PRO A 109 THR A 115 1 N LEU A 112 O LYS A 153 SHEET 3 A 6 VAL A 77 SER A 83 1 N SER A 78 O PRO A 109 SHEET 4 A 6 GLN A 2 GLY A 10 1 N VAL A 7 O VAL A 77 SHEET 5 A 6 LYS A 49 ASP A 57 1 N ASN A 52 O GLN A 2 SHEET 6 A 6 ASN A 39 VAL A 46 -1 N VAL A 46 O LYS A 49 LINK OG1 THR A 17 MG MG A 201 1555 1555 2.08 LINK OG1 THR A 35 MG MG A 201 1555 1555 2.13 LINK O2G GNP A 200 MG MG A 201 1555 1555 2.08 LINK O2B GNP A 200 MG MG A 201 1555 1555 2.13 LINK MG MG A 201 O HOH A 534 1555 1555 2.08 LINK MG MG A 201 O HOH A 535 1555 1555 2.11 SITE 1 AC1 5 THR A 17 THR A 35 GNP A 200 HOH A 534 SITE 2 AC1 5 HOH A 535 SITE 1 AC2 29 GLY A 12 ALA A 13 VAL A 14 GLY A 15 SITE 2 AC2 29 LYS A 16 THR A 17 CYS A 18 PHE A 28 SITE 3 AC2 29 GLU A 31 TYR A 32 PRO A 34 THR A 35 SITE 4 AC2 29 GLY A 60 LYS A 116 ASP A 118 LEU A 119 SITE 5 AC2 29 SER A 158 ALA A 159 LEU A 160 MG A 201 SITE 6 AC2 29 HOH A 470 HOH A 472 HOH A 495 HOH A 534 SITE 7 AC2 29 HOH A 535 HOH A 536 HOH A 537 HOH A 549 SITE 8 AC2 29 HOH A 555 CRYST1 46.440 103.050 43.673 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021533 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009704 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022897 0.00000